Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis.
about
Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis.Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time.Autologous/Allogeneic Hematopoietic Cell Transplantation versus Tandem Autologous Transplantation for Multiple Myeloma: Comparison of Long-Term Postrelapse Survival.Chart review across EU5 in MM post-ASCT patients
P2860
Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Post-Transplant Outcomes in Hi ...... le Myeloma: A CIBMTR Analysis.
@en
Post-Transplant Outcomes in Hi ...... le Myeloma: A CIBMTR Analysis.
@nl
type
label
Post-Transplant Outcomes in Hi ...... le Myeloma: A CIBMTR Analysis.
@en
Post-Transplant Outcomes in Hi ...... le Myeloma: A CIBMTR Analysis.
@nl
prefLabel
Post-Transplant Outcomes in Hi ...... le Myeloma: A CIBMTR Analysis.
@en
Post-Transplant Outcomes in Hi ...... le Myeloma: A CIBMTR Analysis.
@nl
P2093
P2860
P50
P1476
Post-Transplant Outcomes in Hi ...... le Myeloma: A CIBMTR Analysis.
@en
P2093
Amer Beitinjaneh
Amrita Krishnan
Anita D'Souza
Baldeep Wirk
Bipin N Savani
Cristina Gasparetto
David Vesole
Emma C Scott
P2860
P304
P356
10.1016/J.BBMT.2016.07.007
P577
2016-08-02T00:00:00Z